Vidac will use the new funds to initiate a Phase IIb trial of its lead candidate VDA-1102 in patients with actinic keratosis.

Vidac Pharma has secured €600,000 ($645,651) in additional funding to support the clinical development of its two lead cancer candidates. The funding from existing investors, announced at the ...

Osteosarcoma is a rare bone cancer, which accounts for about 1% of all cancers diagnosed in the United ... Determined to ...

Healthy Women Have Cells That Resemble Breast Cancer Nov. 20, 2024 — A new study finds that, in healthy women, some breast cells that otherwise appear normal may contain chromosome abnormalities ...

20, 2024 — A new study finds that, in healthy women, some breast cells that otherwise appear normal may contain chromosome abnormalities typically associated with invasive breast cancer.

Navjot Singh Sidhu recently announced that his wife is clinically cancer-free. She was diagnosed with stage 4 cancer after ...

When Samuel Mackaravitz was tasked with completing a complex Eagle Scout project for his Troop in Emmaus, he immediately knew ...